Skip to main content
PCRX
NASDAQ Life Sciences

Viatris Closes $36.50-a-Share Takeover of Pacira

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$36.49
Mkt Cap
$1.463B
52W Low
$18.8
52W High
$36.665
52W Position info
94% above low
Off High info
at 52W high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

PCRX sits 94% above its 52-week low of $18.8.

Summary

Viatris has closed its acquisition of Pacira at $36.50 per share in cash, the same terms announced on October 8. That price pins Pacira near its 52-week high, so the stock now trades on deal mechanics rather than fundamentals. Viatris expects the acquisition to contribute total revenue of $90 million to $100 million for the remainder of 2026. The close follows Pacira's board recommendation of the tender offer on October 30 and its decision to skip Q3 reporting and withdraw 2026 guidance on November 5. Two New York state suits and fifteen demand letters alleging the 14D-9 omitted material information, disclosed November 12, did not stop the deal from completing. Viatris is the acquirer here; Pacira shareholders receive the fixed cash consideration.

At the time of this announcement, PCRX was trading at $36.49 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $18.80 to $36.67. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

PCRX - Latest Insights

PCRX
Nov 12, 2026, 4:20 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $36.46
Real-time Price: $36.49 info
Change: +$0.030 (+0.08%) info
Market Cap: $1.463B info
PCRX
Nov 12, 2026, 4:15 PM EST
Filing Type: SC 14D9/A
Importance Score:
7
Price at Filing: $36.46
Real-time Price: $36.49 info
Change: +$0.030 (+0.08%) info
Market Cap: $1.463B info
PCRX
Nov 05, 2026, 4:37 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $36.42
Real-time Price: $36.49 info
Change: +$0.070 (+0.19%) info
Market Cap: $1.463B info
PCRX
Nov 05, 2026, 4:33 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $36.42
Real-time Price: $36.49 info
Change: +$0.070 (+0.19%) info
Market Cap: $1.463B info
PCRX
Oct 30, 2026, 8:32 AM EDT
Filing Type: SC 14D9
Importance Score:
8
Price at Filing: $36.35
Real-time Price: $36.49 info
Change: +$0.140 (+0.39%) info
Market Cap: $1.463B info